Document is current
Any future updates will be listed below
-
Authors
Maher, Toby M. http://orcid.org/0000-0001-7192-9149
Strek, Mary E.
-
Funding
Funding for this research was provided by:
Boehringer Ingelheim Pharmaceuticals, Inc. (N/A)
- License Information
-
More Information
Article History
Received: 10 December 2018
Accepted: 12 August 2019
First Online: 6 September 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Outside the submitted work, TMM reports receiving grant funding to his institution and personal fees for service on a clinical trial advisory board from GlaxoSmithKline; personal fees from Boehringer Ingelheim, InterMune/Roche, Sanofi Aventis, AstraZeneca, Biogen Idec, Cipla, Prometic and Sanumed; research fees to his institution; personal fees and non-financial support from UCB; he holds stock options in Apellis. Outside the submitted work, MES reports grants from Boehringer Ingelheim, Novartis, Roche and the National Institutes of Health, and personal fees from Boehringer Ingelheim.
